John Wiley & Sons, Inc. (JW.A): Price and Financial Metrics

John Wiley & Sons, Inc. (JW.A): $52.68

-0.65 (-1.22%)

POWR Rating

Component Grades













JW.A Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for JW.A is 1.83 -- better than 71.87% of US stocks.
  • John Wiley & Sons Inc's stock had its IPO on March 26, 1990, making it an older stock than 84.47% of US equities in our set.
  • In terms of twelve month growth in earnings before interest and taxes, John Wiley & Sons Inc is reporting a growth rate of -102.12%; that's higher than only 18.74% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to John Wiley & Sons Inc are ODP, AIT, PFMT, RCMT, and BNED.
  • Visit JW.A's SEC page to see the company's official filings. To visit the company's web site, go to

JW.A Stock Price Chart Interactive Chart >

Price chart for JW.A

JW.A Price/Volume Stats

Current price $52.68 52-week high $55.54
Prev. close $53.33 52-week low $30.00
Day low $52.22 Volume 386,000
Day high $54.23 Avg. volume 272,850
50-day MA $48.57 Dividend yield 2.6%
200-day MA $38.57 Market Cap 2.95B

John Wiley & Sons, Inc. (JW.A) Company Bio

John Wiley & Sons, Inc. provides knowledge and knowledge-enabled services in the areas of research, professional practice and education. The Company operates through three segments: Research, Professional Development and Education. The company was founded in 1807 and is based in Hoboken, New Jersey.

JW.A Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$52.68$17.91 -66%

Below please find a table outlining a discounted cash flow forecast for JW.A, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that John Wiley & Sons Inc ranked in the 28th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 66.17%. The most interesting components of our discounted cash flow analysis for John Wiley & Sons Inc ended up being:

  • Its compound free cash flow growth rate, as measured over the past 5.46 years, is -0.01% -- higher than just 22.46% of stocks in our DCF forecasting set.
  • John Wiley & Sons Inc's effective tax rate, as measured by taxes paid relative to net income, is at 149 -- greater than 98.35% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 12. This value is greater than 70.18% stocks in the Consumer Cyclical sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of John Wiley & Sons Inc? See SGA, TALN, CBRL, ETM, and ROL.

JW.A Latest News Stream

Event/Time News Detail
Loading, please wait...

JW.A Latest Social Stream

Loading social stream, please wait...

View Full JW.A Social Stream

Latest JW.A News From Around the Web

Below are the latest news stories about John Wiley & Sons Inc that investors may wish to consider to help them evaluate JW.A as an investment opportunity.

Wiley Announces the Acquisition of Hindawi

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons, Inc. (NYSE:JWA) (NYSE:JWB) today announced the acquisition of Hindawi Limited, an innovator in open access (OA) publishing and one of the world's fastest growing scientific research publishers, for a total purchase price of $298 million. The acquisition of Hindawi significantly increases Wiley’s position as a global leader in research by adding quality, scale and growth to the company’s open access publishing program. Open access is a rapid

Business Wire | January 5, 2021

Wiley Reports Second Quarter Fiscal 2021 Results

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons, Inc. (NYSE:JWA)(NYSE:JWB), a global leader in research and education, today announced results for the second quarter ended October 31, 2020. SECOND QUARTER SUMMARY GAAP Results: Revenue of $491 million (+5%) and EPS of $1.22 (+54%) Adjusted Results (at constant currency): Revenue +4% to $491 million, EBITDA +7% to $120 million, and EPS +12% to $1.00 Research Publishing & Platforms (at constant currency): Revenue +5% and Adjusted EBITDA

Business Wire | December 8, 2020

Wiley Accelerates Innovation in Research Publishing

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons Inc., a global leader in research and education, continues to innovate its publishing business, announcing today two technologies that advance how scientific research is published, delivering greater value to researchers. First, the company’s publishing platform provider and subsidiary, Atypon, has successfully piloted its interactive figures technology in the International Journal of Quantum Chemistry, publishing the first scientific articl

Business Wire | October 29, 2020

Medical Publishing Market churn higher on M&A Buzz; IBM, Cambridge University Press, John Wiley & Sons

HTF Market Intelligence released a new research report of 150 pages on title 'Global Medical Publishing Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025' with detailed analysis, forecast and strategies. The study covers key regions

OpenPR | September 30, 2020

Macy's, Carnival: 5 Big Stock Gainers for Thursday

Macy's, Sutro Biopharma, Carnival, John Wiley & Sons and Five Below are rising in a down market Thursday.

The Street | September 3, 2020

Read More 'JW.A' Stories Here

JW.A Price Returns

1-mo 15.50%
3-mo 53.67%
6-mo 69.90%
1-year 46.86%
3-year -9.48%
5-year 37.82%
YTD 15.37%
2020 -2.43%
2019 6.41%
2018 -26.39%
2017 23.42%
2016 23.99%

JW.A Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full JW.A Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8258 seconds.